The disease is active and the options handed to you are running out.
We analyze your tumor's DNA and RNA and lay out the therapies that fit, approved, off-label, trial, or special access, with how to get each one.
For patients with active or recurrent disease, or anyone who wants a second look.
Treatment is done, the scans are clear, and the plan is to wait.
A vaccine designed from the mutations unique to your tumor, made for you, and given by a physician.
For patients with no evidence of disease after treatment, with tumor tissue available.
Both can apply. Which fits is worked out in the first conversation.
Coley Bio was started by a physician-engineer and a patient.
When her rare cancer met "wait and watch," we had the tumor sequenced and a vaccine built from it, across two countries. She is on that vaccine today.
We are making that path available to others.
Patient, family member, or physician. A few lines is enough to start.
Introductory price for the first 10 families
Usually $5,000 now $1,500
For the treatment analysis. Send us the tumor sequencing report, and we lay out the trials, targeted drugs and newer approaches that fit, in plain language.
